You are here

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Ioannina, , Greece
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Coronary Arteriosclerosis, Type 2 Diabetes Mellitus, Cerebrovascular Accident, Dyslipidemia, Peripheral Vascular Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- High cholesterol blood levels (LDL-cholesterol above 100 mg/dL up to 220 mg/dL.

- Triglycerides up to 600 mg/dL.

- History of coronary artery disease (ex.: heart attack, angina), stroke, diabetes or at
high risk of such events.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Pregnancy or lactation, use of high statin doses (>40mg) at baseline, liver or renal
problems

- Use of other drugs that would interfere with evaluation of efficacy or cause safety
problems

- Uncontrolled hypertension, diabetes or hypothyroidism

- Recent cardiac event of procedure

- High baseline CPK levels

NCT00442325
Pfizer
Completed
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]zer.com

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Major Coronary Event, Cerebrovascular Accident, Coronary Artery Bypass Graft, Unstable Angina, Revascularization
NCT00327418
All Genders
40+
Years
Multiple Sites
Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
NCT00527397
All Genders
16+
Years
Multiple Sites
Primary Hyperlipidemia or Mixed Dyslipidemia
NCT02947334
All Genders
18+
Years
Beijing, Beijing

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now